Novavax's updated protein-based Covid-19 vaccine approved by U.S. FDA

FDA signs off on updated protein-based Covid-19 vaccine from Novavax | CNN The US Food and Drug Administration on Tuesday authorized Novavax’s updated protein-based Covid-19 vaccine for people 12 and older. Amanda Sealy, Brenda Goodman CNN

This vaccine is effective against EG.5, the currently dominant coronavirus strain in the United States, and like Pfizer and Moderna’s mRNA vaccines, it has been updated to target the XBB Omicron subvariant.

Novavax’s protein-based approach is a more traditional one for vaccine development than the mRNA vaccines. ...